Optiver Holding’s Integra LifeSciences IART Stock Holding History

Optiver Holding’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-416	Closed	-$5.96K	–	2697
2025 Q3	$5.96K	Buy	+416	New	+$5.7K	﹤0.01%	1601

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Optiver Holding's IART Position: Q4 2025 in Review

Optiver Holding sold out of Integra LifeSciences (IART) in Q4 2025, closing a stake of 416 shares — an estimated $5.96K sold.

Optiver Holding first reported a position in IART in Q3 2025 and held it in 1 quarter. The position peaked at $5.96K in Q3 2025. 204 funds tracked by Wall St. Rank hold IART as of Q4 2025.

Optiver Holding reported no remaining Integra LifeSciences position as of Q4 2025 after selling out during the quarter.
Optiver Holding sold 416 Integra LifeSciences shares in Q4 2025, an estimated $5.96K.
Optiver Holding first reported a position in Integra LifeSciences in Q3 2025 and held it in 1 quarter.
Optiver Holding's Integra LifeSciences position peaked at $5.96K in Q3 2025.
204 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2025.

Based on Optiver Holding's 13F filing for Q4 2025, filed 17 Feb 2026.